Dudediligence.

Amgen Inc

AMGNNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
OptionsOpen the Sheet →FilingsNewest: 10-Q, Quarterly reportAug 4 →InsidersNo open-market buys. 5 insiders sold $25.2M, 0 of 8 sales on a 10b5-1 plan.→HoldersBlackRock 9.1%Vanguard 6.5%State Street 5.7%→Financing →PeersClosest companies: REGN, BIIB, BMRN→

From the filings

Figures

Revenue
$38.09Blast 12 months
Net income
$8.74Blast 12 months
Operating cash flow
$10.76Blast 12 months
Cash and equivalents
$13.99Bat the last balance sheet
Total debt
$57.30Bat the last balance sheet
Shares outstanding
540.6M shareson issue
Every year and quarter →